Criado-Alvarez J J, Rodríguez Caravaca G, Gonseth J, Romo Barrientos C
Instituto de Ciencias de la Salud de Castilla-La Mancha, Consejería de Sanidad, 45600 Talavera de la Reina (Toledo), Spain.
Aten Primaria. 2004 Feb 28;33(3):126-30. doi: 10.1016/s0212-6567(04)79372-5.
To analyze the potential saving in the pharmaceutical cost that would suppose the use of equivalent pharmaceutical specialties and smaller price, in the main groups of pharmaceutical cost in 1998.
Pharmacoepidemiologic study of drug utilization and a pharmaeconomic analysis of minimisation costs.
Primary care of the province of Toledo.
Prescriptions with official medical prescription of the pharmaceutical groups of greater cost during 1998 (peptic antiulcer, hipolipemiants, antagonists of calcium, hipotensors, peripheral vasodilators, macrolids, nonsteroidal antiinflamatories and antirheumatics, antidepressants and bronchodilatadors).
Calculation of consumption by means of defined daily doses, cost of treatment to the day and potential saving.
The potential saving in 1998 in the province of Toledo was 1405 million pesetas, which supposes 25% of the total amount of the pharmaceutical cost. Omeprazol, ranitidin and enalapril with 44.65, 46.02 and 32.84% of variation between prescribed and the cheapest alternative, were the specialties with a greater potential of saving.
The alternative to prescribe equivalent pharmaceutical specialties and of smaller price has a great potential of saving.
分析假设使用等效药品且价格更低时，1998年主要药品费用组中可能节省的药品成本。
药物利用的药物流行病学研究和成本最小化的药物经济学分析。
托莱多省的初级医疗保健机构。
1998年期间开具官方医疗处方的高成本药品组的处方（抗消化性溃疡药、降血脂药、钙拮抗剂、降压药、外周血管扩张剂、大环内酯类、非甾体抗炎药和抗风湿药、抗抑郁药和支气管扩张剂）。
通过限定日剂量计算消耗量、每日治疗成本和潜在节省量。
1998年托莱多省的潜在节省量为14.05亿比塞塔，占药品总成本的25%。奥美拉唑、雷尼替丁和依那普利在处方药品与最便宜替代药品之间的差异分别为44.65%、46.02%和32.84%，是具有更大节省潜力的药品。
开具等效且价格更低的药品替代品具有很大的节省潜力。
